Based on the Dianthus Therapeutics Inc. stock forecast from 6 analysts, the average analyst target price for Dianthus Therapeutics Inc. is USD 43.82 over the next 12 months. Dianthus Therapeutics Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Dianthus Therapeutics Inc. is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Dianthus Therapeutics Inc.’s stock price was USD 26.35. Dianthus Therapeutics Inc.’s stock price has changed by -10.40% over the past week, -4.18% over the past month and +132.98% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for DNTH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
